COVID-19 Reinfects People Who Took Pfizer Antivirus Treatment

Photo credit: Mario Tama / Getty Images. Article by Ron Jefferson. The Science Times – April 28, 2022.

The wide-scale distribution of Paxlovid in hospitals and other medical facilities commenced in December 2021, following the studies on its efficacy. Later on, individuals that took the treatment began to experience better health status, evidently improving their protection against COVID-19 infection. After a five-day treatment with Paxlovid, most people claimed that the effects were enough to protect them from the coronavirus, and many were also reported as COVID-free. But through the months that followed, many patients who took the supposed solution experienced reinfection and were reportedly testing positive and showing symptoms after the treatment. […]

Click here to view original web page at www.sciencetimes.com